Vanderson G. Rocha

Av. Dr. Enéas Carvalho De Aguiar, 255 Cerqueira César, 05403- 000,

Sao Paulo, SP, BR

Expertise in

conditions

Av. Dr. Enéas Carvalho De Aguiar, 255 Cerqueira César, 05403- 000,

Sao Paulo, SP, BR

Overview

Vanderson Rocha practices practicing medicine in Sao Paulo, Brazil.

Rocha is highly rated in 37 conditions, according to our data. Their clinical expertise encompasses Graft Versus Host Disease (GvHD), Leukemia, Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Splenectomy.

They are actively involved in clinical research, co-authoring 411 peer reviewed articles and participating in 3 clinical trials.

Locations

Av. Dr. Enéas Carvalho De Aguiar, 255 Cerqueira César, 05403- 000, Sao Paulo, SP, Brazil

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Multicenter, Randomized, Phase III Registration Trial of Transplantation of NiCord®, Ex Vivo Expanded, UCB-derived, Stem and Progenitor Cells, vs. Unmanipulated UCB for Patients With Hematological Malignancies

Enrollment Status: Completed

Publish Date: February 25, 2026

Intervention Type: Drug, Other

Study Drug: Omidubicel

Study Phase: Phase 3

A Phase 3, Randomized, Open-label, Multicenter Study Comparing Ponatinib Versus Imatinib, Administered in Combination With Reduced-Intensity Chemotherapy, in Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Enrollment Status: Active_not_recruiting

Publish Date: November 26, 2025

Intervention Type: Drug

Study Drugs: Ponatinib, Imatinib, Vincristine, Dexamethasone, Cytarabine, Methotrexate, Prednisone

Study Phase: Phase 3

Randomized, Double-Blind Clinical Trial of Ruxolitinib in Patients With Acute Respiratory Disorder Syndrome Due to SARS-CoV-2 Infection

Enrollment Status: Terminated

Publish Date: April 08, 2021

Intervention Type: Other, Drug

Study Phase: Phase 2/Phase 3

View 2 Less Clinical Trials

411 Total Publications

Integrated TCRγ Clonality Workflow for Molecular Diagnosis in HTLV-1 Carriers and Adult T-Cell Leukemia/Lymphoma.

Journal: Diagnostics (Basel, Switzerland)

Published: May 11, 2026

View All 411 Publications

Frequently Asked Questions about Vanderson G. Rocha

Is Vanderson G. Rocha a top-rated expert for Bone Marrow Transplant?

MediFind is an objective health platform that identifies experts based on real-world data. Vanderson G. Rocha is classified as an Elite expert for Bone Marrow Transplant, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Vanderson G. Rocha participate in research or clinical trials?

Yes. Vanderson G. Rocha has published 411 articles and abstracts on conditions like Bone Marrow Transplant. You can view a list of Vanderson G. Rocha's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Rocha's expertise for a condition

ConditionClose